Латвия - латышский - Zāļu valsts aģentūra

fresenius kabi polska sp.z o.o., poland - mannīts - Šķīdums infūzijām - 10%

Европейский союз - латышский - EMA (European Medicines Agency)

merck sharp & dohme b.v. - doravirine, lamivudīnu, tenofovir disoproxil fumarate - hiv infekcijas - antivirals for treatment of hiv infections, combinations - delstrigo ir indicēts, lai ārstētu pieaugušos ar hiv inficēti 1 bez pagātnes vai tagadnes pierādījumus par pretestību nnrti klases, lamivudīnu, vai tenofovir. delstrigo is also indicated for the treatment of adolescents aged 12 years and older weighing at least 35 kg who are infected with hiv-1 without past or present evidence of resistance to the nnrti class, lamivudine, or tenofovir and who have experienced toxicities which preclude the use of other regimens that do not contain tenofovir disoproxil.

Европейский союз - латышский - EMA (European Medicines Agency)

pinax pharma gmbh - ioflupane (123i) - radionuclide imaging; dementia; movement disorders - diagnostikas radiofarmaceitiskie preparāti - Šīs zāles ir paredzētas tikai diagnostikas vajadzībām. celsunax is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy.  celsunax is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy. pieaugušo pacientu, lai palīdzētu atšķirt ticams, demence ar lewy iestādēm, no alcheimera slimības.  celsunax is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.

Европейский союз - латышский - EMA (European Medicines Agency)

orion corporation - dexmedetomidine hydrochloride - nervu sistēma, citi hypnotics un sedatīviem - suņi - suņu radītā akūtas trauksmes un bailes mazināšana.

Латвия - латышский - Zāļu valsts aģentūra

lek pharmaceuticals d.d., slovenia - pipemidīnskābe - cietās kapsulas - 200 mg

Латвия - латышский - Zāļu valsts aģentūra

vitabalans oy, finland - paracetamolum, kofeīns - tablete - 500 mg/65 mg

Латвия - латышский - Zāļu valsts aģentūra

berlin-chemie ag (menarini group), germany - sulfamethoxazolum, trimethoprimum - tablete - 800 mg/160 mg

Европейский союз - латышский - EMA (European Medicines Agency)

laboratorios farmacéuticos rovi, s.a. - risperidons - Šizofrēnija - psihoterapija - treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone.

Европейский союз - латышский - EMA (European Medicines Agency)

sandoz gmbh - natalizumab - multiple sclerosis, relapsing-remitting; multiple sclerosis - imūnsupresanti - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 un 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.

Латвия - латышский - Zāļu valsts aģentūra

baxter holding b.v., netherlands - natrii citras, natrii chloridum - Šķīdums hemofiltrācijai